DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
Cardiobase
Mediexplorer.it

Search results for "Vitrakvi"

The FDA ( U.S. Food and Drug Administration ) has approved Larotrectinib ( Vitrakvi ), the first oral TRK inhibitor. The approval is for the treatment of adult and pediatric patients with solid tumor ...


The European Commission has granted marketing authorization in the European Union ( EU ) for the precision oncology treatment Vitrakvi ( Larotrectinib ). The drug is indicated for the treatment of a ...